Palonosetron 0.5mg

Palonosetron 0.5mg Capsule Quick Overview

Palonosetron 0.5mg is a prescription antiemetic capsule used to prevent nausea and vomiting caused by chemotherapy. It works by blocking serotonin receptors in the gut and brain that trigger the vomiting reflex. This medication is taken as a single dose before chemotherapy begins, and its use should be directed by your oncology care team based on your specific chemotherapy regimen.

Medical Supervision & Regulatory Status

Palonosetron 0.50mg soft gelatin capsules were approved by the FDA in the United States on August 22, 2008 for preventing chemotherapy-induced nausea and vomiting, and it is available under the brand name ALOXI as well as generic versions. This is a prescription-only medication administered in a clinical setting, typically as part of a chemotherapy treatment plan supervised by an oncologist or infusion team.

Clinical Context

Chemotherapy is often associated with nausea and vomiting, which are among the most unpleasant and distressing side effects of cancer treatment, and this can reduce a patient’s quality of life and even lead to non-compliance or refusal of potentially life-saving chemotherapy. The severity of nausea and vomiting depends on the specific chemotherapy agents and doses used, with regimens classified as highly, moderately, low, or minimally emetogenic (nausea-causing).

Preventive antiemetic treatment is typically planned before chemotherapy begins, rather than after symptoms start, since prevention is far more effective than treating nausea once it has already developed.

Palonosetron 0.5mg oral capsules are specifically indicated in the US for the prevention of acute nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (MEC). It is often used alongside other antiemetic classes, such as NK-1 receptor antagonists or corticosteroids, as part of a combination prevention strategy for higher-risk chemotherapy regimens.

How Palonosetron 0.5mg Works

Palonosetron hydrochloride is a specific 5-hydroxytryptamine type 3 (5-HT3) receptor antagonist. Chemotherapy triggers the release of serotonin in the gut, which activates 5-HT3 receptors and sends signals to the brain’s vomiting center.

By blocking these receptors, palonosetron interrupts this signaling pathway, preventing the nausea and vomiting response before it starts. Its prolonged duration of action offers a notable advantage over other 5-HT3 receptor antagonists, providing extended antiemetic protection.

For patients, this translates into effective, longer-lasting nausea prevention from a single dose, reducing the need for repeated dosing during the acute phase after chemotherapy.

What is Palonosetron 0.5mg?

Uses / Indications

Prevention of chemotherapy-induced nausea and vomiting (CINV): Indicated for prevention of acute nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy

How to Use / Dosage

The recommended dose for adults is 0.5mg (one capsule) taken as a single oral dose about one hour before chemotherapy begins. This capsule may be taken without regard to meals, since a high-fat meal did not affect its absorption.

Because this is a single preventive dose tied to a chemotherapy schedule rather than an ongoing daily medication, there is no “missed dose” or “stopping suddenly” concern in the typical sense — your oncology team will administer or direct the timing of each dose relative to your chemotherapy sessions. Do not take additional doses beyond what is prescribed, as repeat dosing is scheduled specifically around your treatment cycle.

Side Effects

Palonosetron is generally well tolerated as a single preventive dose. Common side effects can include headache, constipation, diarrhea, dizziness, and fatigue.

Serious effects are uncommon but can occur, particularly related to heart rhythm changes or allergic reactions. In clinical studies, the effect of intravenous palonosetron on blood pressure, heart rate, and ECG parameters including the QTc interval was comparable to other 5-HT3 antagonists, and even at high doses it did not prolong the QT interval to a clinically relevant extent.

Emergency Warning Signs — seek medical attention if you experience:

• Signs of an allergic reaction: rash, hives, facial or throat swelling, difficulty breathing
• Fast, slow, or irregular heartbeat
• Severe dizziness or fainting
• Signs of serotonin syndrome: agitation, hallucinations, rapid heart rate, muscle stiffness or twitching, loss of coordination
• Severe or persistent constipation
• Chest pain

Warnings & Precautions

Palonosetron is contraindicated in anyone with a known hypersensitivity to the drug or any of its components, and hypersensitivity reactions, including anaphylaxis, have been reported, sometimes even without a known prior hypersensitivity to other selective 5-HT3 receptor antagonists.

Serotonin syndrome, involving altered mental status, autonomic instability, and neuromuscular symptoms, has been described following concomitant use of 5-HT3 receptor antagonists like palonosetron together with other serotonergic drugs, including SSRIs and SNRIs, so this combination requires careful monitoring. Overall, the potential for clinically significant drug interactions with palonosetron appears to be low, and a study combining oral metoclopramide with palonosetron showed no significant pharmacokinetic interaction, as did concomitant use of an aluminum/magnesium antacid. There are no adequate and well-controlled studies of palonosetron use in pregnant women, so use during pregnancy should be discussed carefully with your oncology team, weighing risks and benefits. Since this medication is used specifically around chemotherapy administration, your care team will coordinate timing with your full antiemetic and chemotherapy regimen.

Who Should Not Use This Medication

Anyone with a known hypersensitivity to palonosetron or its components
Use combined with other serotonergic medications without oncology team review, due to serotonin syndrome risk
Self-administration outside of a supervised chemotherapy treatment plan
Use for indications outside chemotherapy-related nausea prevention, without a doctor’s direction

Storage Instructions

Store at room temperature, protected from excessive heat and moisture. Keep capsules in their original packaging. Keep out of reach of children, and this medication should only be handled and administered as directed by your treating clinical team.

Frequently Asked Questions

Is a prescription needed for Palonosetron 0.5mg?

Yes, this is a prescription-only medication administered as part of a chemotherapy treatment plan under your oncology team’s supervision.

How long does it take to work?

After a single oral dose, peak blood levels are typically reached around 5 hours later, and the medication provides extended antiemetic protection well beyond the initial dosing window. It is taken about an hour before chemotherapy to ensure protection is in place when treatment begins.

Is it safe to stop using it early?

This medication is given as a single preventive dose per chemotherapy cycle rather than an ongoing daily treatment, so there’s no tapering or “stopping” process — your oncology team manages dosing timing around each chemotherapy session.

Can it interact with other medicines?

Yes, combining it with other serotonergic medications like SSRIs or SNRIs can increase the risk of serotonin syndrome, though overall interaction potential is considered low. Your oncology team will review your full medication list before each dose.

What if a dose is missed relative to chemotherapy timing?

Since dosing is tied directly to your chemotherapy schedule, your clinical team manages the timing — contact them promptly if there’s any concern about a dose not being given as planned.

What is the cost without insurance?

The cost without insurance depends on the seller, brand availability, and pack size, and may also vary by location and available discounts, as well as whether it’s administered as part of a hospital or infusion center visit.

Is Palonosetron available over the counter?

No, it is not available over the counter in any country and requires a prescription as part of a supervised chemotherapy treatment plan.

References:

FDA – ALOXI (Palonosetron) Capsules Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022233s005lbl.pdf

FDA – Palonosetron Hydrochloride Injection Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208109s001lbl.pdf

Pfizer Labeling – Palonosetron Hydrochloride Injection Full Prescribing Information: https://labeling.pfizer.com/ShowLabeling.aspx?id=11311

Medical Disclaimer:

This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified specialist or physician before using Palonosetron 0.5mg.